{"url_path":"/sec/syra/8-k/2026-08-11/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Conditions.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1922335/0001493152-26-036995-index.html","accession_number":"0001493152-26-036995","cik":"0001922335","ticker":"SYRA","issuer_name":"Syra Health Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1922335/0001493152-26-036995-index.html","primary_entity_key":"0001922335","primary_entity_name":"Syra Health Corp"},"word_count":151,"has_tables":true,"body_markdown":"**Item\n2.02. Results of Operations and Financial Conditions.**\n\n** **\n\nOn\nAugust 11, 2026, Syra Health Corp. issued a press release announcing its financial results for the second quarter ended June 30, 2026.\nA copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.\n\n \n\nThe\ninformation in this report, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities\nand Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall\nnot be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be\nexpressly set forth by specific reference in such a filing. In addition, the exhibit furnished herewith contain statements intended as\n“forward-looking statements” that are subject to the cautionary statements about forward-looking statements set forth in\nsuch exhibit."}